2020
DOI: 10.21203/rs.3.rs-64034/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Cost Analysis of Options for Schistosomiasis Control Mda Programs Targeting Children Aged Five Years and Below in Umkhanyakude District of Kwazulu-natal Province, South Africa

Abstract: BackgroundSchistosomiasis negatively impacts early childhood development. Inclusion of children aged five years and below in mass drug administration (MDA) programs for controlling schistosomiasis could improve early childhood development in communities where the disease is endemic. We estimated the projected cost of implementing a schistosomiasis control MDA program for children aged five years and below in the uMkhanyakude district of South Africa.MethodWe calculated the cost of implementing a schistosomiasi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…Most studies on the economic evaluation of MDAs for various diseases show that they are cost-effective strategies. These studies are LF-MDA in the Philippines [ 5 ]; LF-MDA in Haiti [ 6 ]; trachoma MDA in South Sudan [ 7 ]; systematic review of economic evaluations of LF interventions [ 8 ]; overview of the MDA programme [ 9 ]; scabies MDA in Fiji [ 10 ]; malaria MDA modelling [ 11 ]; schistosomiasis MDA in South Africa [ 12 ]; focal malaria prevention MDA in Zambia [ 13 ]; programmatic cost of targeted mass drug administration for malaria in Myanmar [ 14 ]; and assessment of the health economic studies of Global Programme to Eliminate Lymphatic Filariasis (GPELF) [ 15 ]. Thus, the current study sought to answer the following questions: (1) What is the financial cost of the LF-MDA in Ghana?…”
Section: Introductionmentioning
confidence: 99%
“…Most studies on the economic evaluation of MDAs for various diseases show that they are cost-effective strategies. These studies are LF-MDA in the Philippines [ 5 ]; LF-MDA in Haiti [ 6 ]; trachoma MDA in South Sudan [ 7 ]; systematic review of economic evaluations of LF interventions [ 8 ]; overview of the MDA programme [ 9 ]; scabies MDA in Fiji [ 10 ]; malaria MDA modelling [ 11 ]; schistosomiasis MDA in South Africa [ 12 ]; focal malaria prevention MDA in Zambia [ 13 ]; programmatic cost of targeted mass drug administration for malaria in Myanmar [ 14 ]; and assessment of the health economic studies of Global Programme to Eliminate Lymphatic Filariasis (GPELF) [ 15 ]. Thus, the current study sought to answer the following questions: (1) What is the financial cost of the LF-MDA in Ghana?…”
Section: Introductionmentioning
confidence: 99%